Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3059-3063

  Cai, Yingna ^a   Wu, Michael H ^a   Ludeman, Susan M ^b   Grdina, David J ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; ACROLEIN; CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE DERIVATIVE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHORAMIDE MUSTARD; DNA ALKYLTRANSFERASE; DRUG DERIVATIVE; MUTAGENIC AGENT; PERFOSFAMIDE; RECOMBINANT PROTEIN; TRANSFERASE;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL STRAIN; CELL SURVIVAL; CHO CELL; CYTOTOXICITY; DRUG SENSITIVITY; LEUKEMIA; MUTAGENICITY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; DNA REPAIR; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; METABOLISM; RADIATION EXPOSURE;

ALKYL AND ARYL TRANSFERASES; ANIMALS; CELL SURVIVAL; CHO CELLS; CRICETINAE; CYCLOPHOSPHAMIDE; DNA REPAIR; HUMANS; MUTAGENS; PHOSPHORAMIDE MUSTARDS; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0033153762     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 6-alkylguanine-DNA alkyltransferase. Progress Nucleic Acid Res. Mol. Biol. 51: 167-223, 1995.
2. 6-alkylguanine-DNA alkyltransferase. Science (Washington DC), 259: 219-222, 1993.
3. Gibbons, R. B., and Westerman, E. Acute non-lymphocytic leukemia following short-term, intermittent, intravenous cyclophosphamide treatment of lupus nephritis. Arthritis Rheum., 31: 1552-1554, 1988.
4. Ortiz, A., Gonzalez-Parra, E., Aloarez-Costa, G., and Egido, J. Bladder cancer after cyclophosphamide therapy for lupus nephritis. Nephron, 60: 378-379, 1992.
5. Anderson, D., Bishop, J. B., Garner, R. C., Ostrosky-Wegman, P., and Selby, P. B. Cyclophosphamide. Review of its mutagenicity for an assessment of potential germ cell risks. Mutat. Res., 330: 115-181, 1995.
6. 2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res., 44: 990-995, 1984.
7. Hemminki, K. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice. Cancer Res., 45: 4237-4243, 1985.
8. Jacobson-Kram, D., Albertini, R. J., Branda, R. F., Falta, M. T., Iype, P. T., Kolodner, K., Liou, S., McDiarmid, M. A., Morris, M., Nicklas, J. A., O'Neill, J. P., Poirier, M. C., Putman, D., Strickland, P. T., William, J. R., and Xiao, S. Measurement of chromosomal aberration sister chromatid exchange, hprt mutation and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer. Environ. Health Perspect. Suppl., 101: 121-125, 1993.
9. 6-Methylguanine-DNA methyltransferase in ovarian malignancy and its correlation with postoperative response to chemotherapy. Gynecol. Oncol., 52: 172-174, 1994.
10. Codegoni, A. M., Broggini, M., Pitelli, M. R., Pantapotto, M., Torri, V., Mangioni, C., and Incalci, M. D. Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer, Gynecol. Oncol., 65: 130-137, 1997.
11. 6-alkylguanine-DNA alkyltransferase. Cancer Chemother. Pharmacol., 43: 80-85, 1998.
12. Zon, G., Ludeman, S. M., Brandt, J. A., Boyd, V. L., Ozkan, G., Egan, W., and Shao, K. L. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation path ways. J. Med. Chem., 27: 466-485, 1984.
13. Wahl, G. M., Lewis, K. A., Ruiz, J. C., Rothenberg, B., Zhao, J., and Evan, G. A. Cosmid vectors for rapid genomic walking, restriction mapping, and gene transfer. Proc. Natl. Acad. Sci. USA, 84: 2160-2164, 1987.
14. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 5368-5372, 1990.
15. 6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. Cancer Res., 51: 3367-3372, 1991.
16. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72: 248-254, 1976.
17. 6-methylguanine DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis (Lond.), 5: 1641-1647, 1984.
18. 6-Methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int. J. Cancer, 77: 919-922, 1998.
19. 6-methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int. J. Cancer, 65: 506-512, 1996.
20. 6-alkylguanine-DNA alkyltransferase of human tumor xenografts. Eur. J. Cancer, 34: 1749-1755, 1998.
21. Crook, T. R., Souhami, R. L., Whyman, G. D., and Mclean, A. E. M. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide. Cancer Res., 46: 5035-5038, 1986.
22. Cohen, S. M., Garland, E. M., John, M., Okamura, T., and Smith, R. Acrolein initiates rat urinary bladder carcinogenesis. Cancer Res., 52: 3577-3581, 1992.
23. 6-benzylguanine plus BCNU. Blood, 88: 1649-1655, 1996.
24. 6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia. Cancer Res., 48: 3084-3089, 1988.
25. 6-alkylguanine-DNA alkyltransferase activity in peripheral lymphocytes of patients undergoing bone marrow transplantation. Br. J. Cancer, 66: 331-336, 1992.
26. 6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts. Carcinogenesis (Lond.), 6: 1755-1759, 1985.
27. Wlodek, L. The reaction of sulfhydryl groups with carbonyl compounds. Acta Biochim. Pol., 35: 307-317, 1988.